 |
|
Clinical trial evaluating brain cancer vaccine is underway at NYU
October 22, 2007A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center. The study will evaluate the addition of the vaccine following standard therapy with surgery and chemotherapy in patients with glioblastoma multiforme, a deadly form of brain cancer.
The vaccine, called DCVax-Brain, incorporates proteins found in patients' tumors and is designed to attack cancer cells containing these proteins. The study underway at NYU Medical Center is an expansion of an earlier phase I trial of the vaccine. The vaccine is made by the Northwest Biotherapeutics, Inc., based in Bothell, Washington.
"We are really excited about the promise of this vaccine," said Patrick J. Kelly, M.D., the chairman of the Department of Neurosurgery and the Joseph Ransohoff Professor of Neurosurgery at NYU School of Medicine. "Everything now depends on something in addition to surgery so that these tumors do not recur. A cancer vaccine like this may make a difference in extending life and maintaining a good quality of life."
"This is a form of individualized therapy," adds NYU neuro-oncologist Michael Gruber, M.D. "There is a lot of promise with this approach," he says. He and Dr. Kelly will be the lead investigators conducting the trial at NYU.
Despite surgery and chemotherapy, patients with glioblastoma multiforme brain cancer typically survive about 15 months. Even if only a small number of tumor cells are left in the brain, that is enough for these fast growing and aggressive tumors to grow back. The tumors do not grow elsewhere in the body. "It is so frustrating," notes Dr. Kelly, "because brain tumors don't metastasize like other tumors. They recur locally but we just can't cure it."
A brain cancer vaccine is intended as a kind of immunotherapy, which means that it primes the patient's own immune system to kill proteins found in cancer cells. The trial will enroll patients 18 to 65 years old with newly diagnosed glioblastoma multiforme brain cancer who will receive standard primary treatment with surgery followed by radiation with concurrent chemotherapy. Enrolled patients will be randomized to receive the standard of care, and others will receive the standard of care and the vaccine.
The vaccine will be made from the tumors and immune cells of each patient. When a patient's tumor is removed during surgery it will be shipped to a laboratory where the tumor cells will be broken up to prepare the first component of the vaccine. Separately, patients' dendritic cells, a powerful type of immune cell, will be obtained and sent to a laboratory for purification. Dendritic cells may be able to teach the immune system to recognize and destroy cancer cells. The patients' tumor cell material is combined with the dendritic cells to form the vaccine.
New York University Medical Center and School of Medicine
"This is a form of individualized therapy," adds NYU neuro-oncologist Michael Gruber, M.D. "There is a lot of promise with this approach," he says. He and Dr. Kelly will be the lead investigators conducting the trial at NYU.
Despite surgery and chemotherapy, patients with glioblastoma multiforme brain cancer typically survive about 15 months. Even if only a small number of tumor cells are left in the brain, that is enough for these fast growing and aggressive tumors to grow back. The tumors do not grow elsewhere in the body. "It is so frustrating," notes Dr. Kelly, "because brain tumors don't metastasize like other tumors. They recur locally but we just can't cure it."
A brain cancer vaccine is intended as a kind of immunotherapy, which means that it primes the patient's own immune system to kill proteins found in cancer cells. The trial will enroll patients 18 to 65 years old with newly diagnosed glioblastoma multiforme brain cancer who will receive standard primary treatment with surgery followed by radiation with concurrent chemotherapy. Enrolled patients will be randomized to receive the standard of care, and others will receive the standard of care and the vaccine.
The vaccine will be made from the tumors and immune cells of each patient. When a patient's tumor is removed during surgery it will be shipped to a laboratory where the tumor cells will be broken up to prepare the first component of the vaccine. Separately, patients' dendritic cells, a powerful type of immune cell, will be obtained and sent to a laboratory for purification. Dendritic cells may be able to teach the immune system to recognize and destroy cancer cells. The patients' tumor cell material is combined with the dendritic cells to form the vaccine.
New York University Medical Center and School of Medicine
Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Endangered Species Quasar Stress Allergic Reactions Groundwater Neurogenesis Cistic Fibrosis Transcription Influenza Virus Logging Nicotine Antiretroviral Therapy Polycystic kidney disease Biofilm Prions Cocaine Osteoarthritis Clinical Trials Volcanic Activity Hypertension Renewable energy Fishing Insulin Resistance Heterochromatin Vitamin
See More: Science News Tags
Brain Cancer Current Events and Brain Cancer News RSSUAB Researchers Draft 3-D Protein Map
A new three-dimensional computer protein map is helping researchers at the University of Alabama at Birmingham (UAB) unravel the biological pathways that control brain-cell death after a stroke.
Most common brain cancer may originate in neural stem cells
University of Michigan scientists have found that a deficiency in a key tumor suppressor gene in the brain leads to the most common type of adult brain cancer.
Cottonseed-Based Drug Shows Promise Treating Severe Brain Cancer, Say UAB Researchers
An experimental drug derived from cottonseeds shows promise in treating the recurrence of glioblastoma multiforme, widely considered the most lethal brain cancer.
Tumor growth and chemo response may be predicted by mathematical model
The aggressiveness of tumors and their susceptibility to chemotherapy may become easier to predict based on a mathematical model developed at The University of Texas Health Science Center at Houston.
Moving gene therapy forward with mobile DNA
Gene therapy is the introduction of genetic material into a patient's cells resulting in a cure or a therapeutic effect. In recent years, it has been shown that gene therapy is a promising technology to treat or even cure several fatal diseases for which there is no attractive alternative therapy.
NASA's electronic nose may provide neurosurgeons with a new weapon against brain cancer
An unlikely multidisciplinary scientific collaboration has discovered that an electronic nose developed for air quality monitoring on Space Shuttle Endeavour can also be used to detect odour differences in normal and cancerous brain cells.
Novel cancer drug reduces neuroblastoma growth by 75 percent
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found a new drug that restricts the growth of neuroblastoma, a childhood brain cancer.
First noninvasive technique to accurately predict mutations in human brain tumors
Donald O'Rourke, MD, Associate Professor of Neurosurgery at the University of Pennsylvania School of Medicine and colleagues, were able to accurately predict the specific genetic mutation that caused brain cancer in a group of patients studied using magnetic resonance imaging (MRI).
TGen researchers discover possible way to block the spread of deadly brain tumors
Researchers at the Translational Genomics Research Institute (TGen) may have found a way to stop the often-rapid spread of deadly brain tumors.
Brain metastases hijack neuron-supporting cells to resist chemotherapy
Cancer that spreads to other organs finds a particularly inviting hideout in the brain, where these metastases are usually far harder to treat than they are in other locations.
More Brain Cancer Current Events and Brain Cancer News Articles
 |
Surviving Terminal Cancer: Clinical Trials, Drug Cocktails, and Other Treatments Your Oncologist Won't Tell You About by Ben A. Williams (Author) (Fairview Press) Univ. of California, San Diego. Consumer text explains how patients can improve their odds for survival by demanding control over their health care, research conventional and alternative treatments, creating their own treatment strategy, and using the Internet to learn of new medical advances. Softcover. |
 |
Chemotherapy - Questions and Answers about Chemotherapy and Cancer Treatments. Everything You Need to Know about Chemotherapy About This Book Chemotherapy and You is written for you - someone who is about to receive or is now receiving chemotherapy for cancer. Your family, friends, and others close to you may also want to read this book. This book is a guide you can refer to throughout your chemotherapy treatment. It includes facts about chemotherapy and its side effects and also highlights ways you can care for yourself before, during, and after treatment. Rather than read this book from beginning to end, look at just those sections you need now. Later, you can always read more. This book covers: * Questions and answers about chemotherapy. Answers common questions, such as what chemotherapy is and how it affects cancer cells. * Side effects and ways to manage them.... |
 |
Brain Cancer, Kids Light T-Shirt |
 |
Ted Kennedy Has Brain Cancer - Manson by Bubba the Love Sponge |
 |
Living with a Brain Tumor: Dr. Peter Black's Guide to Taking Control of Your Treatment by Peter Black (Author) Each year, 100,000 people in the United States are diagnosed with a brain tumor. With his new book, Dr. Peter Black fills a gap in the lay readership, providing an accessible medical resource for adult patients and their families. Dr. Black, who has operated on more than 3,000 patients with brain tumors, is uniquely qualified to discuss both clinical treatment of and research into brain tumors. This invaluable resource tells patients everything they need to know to understand and address their diagnosis, in a four-part structure: • “What is a Brain Tumor?" provides straightforward information about how brain tumors are diagnosed, the different types of tumors and how they develop, and where to go for treatment. • “Coping with Shock” addresses the emotional... |
 |
Cancer Be Gone Guided imagery CD taps into the immense power of the mind to enhance comfort, healing, an optimistic attitude and positive expectations. Metaphor of "cancer as weeds in a garden that are easily managed". |
 |
Clearly Charming Gray Ribbon Diabetes, Brain Cancer Awareness Italian Charm Gray ribbon stands for brain cancer awareness. It will make a great addition to your Italian charm bracelet or a perfect personalized gift. Commemorate special occasions, capture memorable moments, or simply show off your birthstone by creating your own original Italian charm bracelet. Add Clearly Charming premium quality interlocking modular Italian charm links to your Italian Charm Bracelet and create your own memory bracelet. |
 |
Brain Cancer, Infant/Toddler T-Shirt |
 |
Brain Cancer Awareness Ribbon Mouse Pad by MyHeritageWear.com The Brain Cancer Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Brain Cancer Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Brain Cancer Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
|
Hope Springs for Brain Cancer by Expressions from the Heart Designed with gift giving and memento keeping in mind, each mouth-blown, glass, heart-shaped ornament features a waffle-like texture into which 160 Swarovski crystals are set. The evocative line offers a fresh and very sentimental option for ornament lovers seeking an alternative to just another tree trimming collectible. Each spectacular piece is suspended from an elegant, bow-trimmed, ribbon and comes packaged, for giving and keeping, in a lovely, high-quality box. Each design has its own special name, accompanied by an evocative story, presented on a story card within the gift box. |
| © 2009 BrightSurf.com |